Literature DB >> 22714729

The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging.

Assaf Tal1, Ivan I Kirov, Robert I Grossman, Oded Gonen.   

Abstract

Since the brain's gray matter (GM) and white matter (WM) metabolite concentrations differ, their partial volumes can vary the voxel's ¹H MR spectroscopy (¹H-MRS) signal, reducing sensitivity to changes. While single-voxel ¹H-MRS cannot differentiate between WM and GM signals, partial volume correction is feasible by MR spectroscopic imaging (MRSI) using segmentation of the MRI acquired for VOI placement. To determine the magnitude of this effect on metabolic quantification, we segmented a 1-mm³ resolution MRI into GM, WM and CSF masks that were co-registered with the MRSI grid to yield their partial volumes in approximately every 1 cm³ spectroscopic voxel. Each voxel then provided one equation with two unknowns: its i- metabolite's GM and WM concentrations C(i) (GM) , C(i) (WM) . With the voxels' GM and WM volumes as independent coefficients, the over-determined system of equations was solved for the global averaged C(i) (GM) and C(i) (WM) . Trading off local concentration differences offers three advantages: (i) higher sensitivity due to combined data from many voxels; (ii) improved specificity to WM versus GM changes; and (iii) reduced susceptibility to partial volume effects. These improvements made no additional demands on the protocol, measurement time or hardware. Applying this approach to 18 volunteered 3D MRSI sets of 480 voxels each yielded N-acetylaspartate, creatine, choline and myo-inositol C(i) (GM) concentrations of 8.5 ± 0.7, 6.9 ± 0.6, 1.2 ± 0.2, 5.3 ± 0.6 mM, respectively, and C(i) (WM) concentrations of 7.7 ± 0.6, 4.9 ± 0.5, 1.4 ± 0.1 and 4.4 ± 0.6mM, respectively. We showed that unaccounted voxel WM or GM partial volume can vary absolute quantification by 5-10% (more for ratios), which can often double the sample size required to establish statistical significance.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714729      PMCID: PMC3449040          DOI: 10.1002/nbm.2812

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  37 in total

1.  A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy.

Authors:  J Hu; T Javaid; F Arias-Mendoza; Z Liu; R McNamara; T R Brown
Journal:  J Magn Reson B       Date:  1995-09

2.  Multimodal image coregistration and partitioning--a unified framework.

Authors:  J Ashburner; K Friston
Journal:  Neuroimage       Date:  1997-10       Impact factor: 6.556

3.  Noise in MRI.

Authors:  A Macovski
Journal:  Magn Reson Med       Date:  1996-09       Impact factor: 4.668

4.  Selective Fourier transform localization.

Authors:  H R Brooker; T H Mareci; J T Mao
Journal:  Magn Reson Med       Date:  1987-11       Impact factor: 4.668

5.  Longitudinal inter- and intra-individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T.

Authors:  Ivan I Kirov; Ilena C George; Nikhil Jayawickrama; James S Babb; Nissa N Perry; Oded Gonen
Journal:  Magn Reson Med       Date:  2011-06-07       Impact factor: 4.668

6.  Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy.

Authors:  Belinda S Y Li; Hao Wang; Oded Gonen
Journal:  Magn Reson Imaging       Date:  2003-10       Impact factor: 2.546

7.  Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis.

Authors:  Yulin Ge; Robert I Grossman; James S Babb; Marcie L Rabin; Lois J Mannon; Dennis L Kolson
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation.

Authors:  Frank Träber; Wolfgang Block; Rolf Lamerichs; Jürgen Gieseke; Hans H Schild
Journal:  J Magn Reson Imaging       Date:  2004-05       Impact factor: 4.813

9.  Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain.

Authors:  T J Doyle; B J Bedell; P A Narayana
Journal:  Magn Reson Med       Date:  1995-06       Impact factor: 4.668

10.  Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation.

Authors:  H P Hetherington; J W Pan; G F Mason; D Adams; M J Vaughn; D B Twieg; G M Pohost
Journal:  Magn Reson Med       Date:  1996-07       Impact factor: 4.668

View more
  31 in total

1.  Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Authors:  Tatsunobu Natsubori; Hideyuki Inoue; Osamu Abe; Yosuke Takano; Norichika Iwashiro; Yuta Aoki; Shinsuke Koike; Noriaki Yahata; Masaki Katsura; Wataru Gonoi; Hiroki Sasaki; Hidemasa Takao; Kiyoto Kasai; Hidenori Yamasue
Journal:  Schizophr Bull       Date:  2013-09-10       Impact factor: 9.306

2.  Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.

Authors:  Shefali Chaudhary; S Senthil Kumaran; Vinay Goyal; M Kalaivani; Gauri Shanker Kaloiya; Rajesh Sagar; Nalin Mehta; Achal Kumar Srivastava; N R Jagannathan
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

3.  N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI.

Authors:  Elan J Grossman; Ivan I Kirov; Oded Gonen; Dmitry S Novikov; Matthew S Davitz; Yvonne W Lui; Robert I Grossman; Matilde Inglese; Els Fieremans
Journal:  Neuroimage       Date:  2015-05-30       Impact factor: 6.556

4.  Spectral decomposition for resolving partial volume effects in MRSI.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Radka Stoyanova; Andrew A Maudsley
Journal:  Magn Reson Med       Date:  2017-11-11       Impact factor: 4.668

5.  Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.

Authors:  Dolores Malaspina; Thorsten M Kranz; Adriana Heguy; Sheila Harroch; Robert Mazgaj; Karen Rothman; Adam Berns; Sumya Hasan; Daniel Antonius; Raymond Goetz; Mariana Lazar; Moses V Chao; Oded Gonen
Journal:  Schizophr Res       Date:  2016-02-28       Impact factor: 4.939

6.  Myo-inositol mediates the effects of traffic-related air pollution on generalized anxiety symptoms at age 12 years.

Authors:  Kelly J Brunst; Patrick H Ryan; Mekibib Altaye; Kimberly Yolton; Thomas Maloney; Travis Beckwith; Grace LeMasters; Kim M Cecil
Journal:  Environ Res       Date:  2019-05-11       Impact factor: 6.498

Review 7.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

8.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

9.  Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.

Authors:  E J Meyer; I I Kirov; A Tal; M S Davitz; J S Babb; M Lazar; D Malaspina; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-21       Impact factor: 3.825

10.  Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study.

Authors:  Ivan I Kirov; Assaf Tal; James S Babb; Yvonne W Lui; Robert I Grossman; Oded Gonen
Journal:  J Neurol       Date:  2012-08-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.